Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Simultaneous Assessment of Total Metabolic Tumor Volume and Intratumoral CD4+ T-Cell Infiltration Identifies Early Progression of Follicular Lymphoma on Watch-and-Wait Approach

Fuminari Fujii, Daisuke Ikeda, Hajime Sakuma, Mitsuaki Oura, Masanori Toho, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 3042.

https://doi.org/10.1182/blood-2024-210742

Published: 2024

Journal Articles

Serum BCMA Is a Better Reflector of Tumor Volume Than IgM in the Induction Period of Waldenström Macroglobulinemia

Mitsuaki Oura, Daisuke Ikeda, Chiho Misono, Shuichi Aikawa, Fuminari Fujii, Hajime Sakuma, Masanori Toho, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Tomohisa Watari, Yoshihito Otsuka, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 3035.

https://doi.org/10.1182/blood-2024-202282

Published: 2024

Journal Articles

Total Diffusion Volume Evaluated By Whole-Body Diffusion Weighted Magnetic Resonance Image for the Assessment of Tumor Burden in Multiple Myeloma; Relations with Measurable Residual Disease Evaluated By Next-Generation Flow Cytometry and Bone Marrow CD138 Staining Assessed By Qupath

Kentaro Narita, Youichi Machida, Daisuke Ikeda, Rikako Tabata, Atsushi Uehara, Mitsuaki Oura, Fuminari Fujii, Hajime Sakuma, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 491.

https://doi.org/10.1182/blood-2024-199873

Published: 2024

Journal Articles

Soluble BCMA As a Surrogate Biomarker for Tumor Burden in Multiple Myeloma: Correlations with Various Biomarkers and Treatment Responses

Rikako Tabata, Mitsuaki Oura, Daisuke Ikeda, Shuichi Aikawa, Chiho Misono, Fuminari Fujii, Hajime Sakuma, Masanori Toho, Atsushi Uehara, Kentaro Narita, Masami Takeuchi, Tomohisa Watari, Yoshihito Otsuka, Kosei Matsue

Blood (2024) 144 (Supplement 1): 3313.

https://doi.org/10.1182/blood-2024-211840

Published: 2024

Journal Articles

Different Patterns of Antigen Expression in Bone Marrow and Circulating Tumor Plasma Cells in Patients with MGUS and Smoldering Multiple Myeloma

Atsushi Uehara, Fuminari Fujii, Hajime Sakuma, Mitsuaki Oura, Masanori Toho, Daisuke Ikeda, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 4682.

https://doi.org/10.1182/blood-2024-206782

Published: 2024

Journal Articles

Soluble B-Cell Maturation Antigen Levels for Disease Monitoring in Oligo- and Non-Secretory Relapsed Multiple Myeloma

Daisuke Ikeda, Shuichi Aikawa, Chiho Misono, Mitsuaki Oura, Fuminari Fujii, Hajime Sakuma, Masanori Toho, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Tomohisa Watari, Yoshihito Otsuka, Kosei Matsue

Blood (2024) 144 (Supplement 1): 366.

https://doi.org/10.1182/blood-2024-207595

Published: 2024

Journal Articles

Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma

Blood blood.2024026028.

https://doi.org/10.1182/blood.2024026028

Published: 2024

Includes: Supplemental data

Journal Articles

Development of a Novel Nomogram for Predicting Delayed Methotrexate Excretion in Adult Patients with Hematologic Malignancies

Daisuke Ikeda, Tatsuya Isezaki, Satoshi Yuyama, Kentaro Narita, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Masami Takeuchi, Kosei Matsue

Blood (2023) 142 (Supplement 1): 4498.

https://doi.org/10.1182/blood-2023-190539

Published: 2023

Journal Articles

Lower Prognostic Performance of the International Metabolic Prognostic Index Compared to the Conventional IPI and NCCN-IPI in a Real-World Cohort of Diffuse Large B-Cell Lymphoma

Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Kosei Matsue

Blood (2023) 142 (Supplement 1): 4493.

https://doi.org/10.1182/blood-2023-189352

Published: 2023

Journal Articles

A Prognostic Model Integrating Circulating Clonal Plasma Cells into R-ISS and PET-CT Based Tumor Burden in Transplant-Ineligible Multiple Myeloma

Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Kosei Matsue

Blood (2023) 142 (Supplement 1): 1972.

https://doi.org/10.1182/blood-2023-189137

Published: 2023

NARROW

Simultaneous Assessment of Total Metabolic Tumor Volume and Intratumoral CD4+ T-Cell Infiltration Identifies Early Progression of Follicular Lymphoma on Watch-and-Wait Approach

Serum BCMA Is a Better Reflector of Tumor Volume Than IgM in the Induction Period of Waldenström Macroglobulinemia

Total Diffusion Volume Evaluated By Whole-Body Diffusion Weighted Magnetic Resonance Image for the Assessment of Tumor Burden in Multiple Myeloma; Relations with Measurable Residual Disease Evaluated By Next-Generation Flow Cytometry and Bone Marrow CD138 Staining Assessed By Qupath

Soluble BCMA As a Surrogate Biomarker for Tumor Burden in Multiple Myeloma: Correlations with Various Biomarkers and Treatment Responses

Different Patterns of Antigen Expression in Bone Marrow and Circulating Tumor Plasma Cells in Patients with MGUS and Smoldering Multiple Myeloma

Soluble B-Cell Maturation Antigen Levels for Disease Monitoring in Oligo- and Non-Secretory Relapsed Multiple Myeloma

Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma

Development of a Novel Nomogram for Predicting Delayed Methotrexate Excretion in Adult Patients with Hematologic Malignancies

Lower Prognostic Performance of the International Metabolic Prognostic Index Compared to the Conventional IPI and NCCN-IPI in a Real-World Cohort of Diffuse Large B-Cell Lymphoma

A Prognostic Model Integrating Circulating Clonal Plasma Cells into R-ISS and PET-CT Based Tumor Burden in Transplant-Ineligible Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only